When mantle cell lymphoma progresses after the first line of treatments, what are the next steps?

Topic Tags:  
Topic Tags:  
Diseases:  
Diseases:  
Emailz
1
Expert Answers

JiaRuanMDPhD (Physician - Oncology - Hematology/Oncology (Verified) ) - 08 / 04 / 2012

As we discussed earlier, MCL tends to run a relapsing course. Managing patients with recurrent or progressive disease after first line therapy is a major component of practice for specialists who care for lymphoma patients. There are many options, both chemotherapy-based, and biologics, that are available for patients whose lymphomas progress after the first line of treatment. The general principle of chemotherapy-based salvage therapy is to apply new combination that the tumors may still be sensitive to. The list of notable biologic options includes bendamustine, bortezomib and lenalidomide, among others. Again, I would highly recommend that patients participate in well-designed clinical trials. One sample of a promising targeted therapy for MCL is a compound called BTK Inhibitor PCI-32765 which is in phase II clinical trials. There are many such examples available in major lymphoma research centers.
Join Now to ask a follow-up question or share your experience!
We'll help guide and support you through treatments.
Similar Questions
What factors are currently used to determine how aggressive a mantle cell lymphoma is?
What tests and metrics are followed during treatment of mantle cell lymphoma?
In what situations is a bone marrow transplant considered to treat mantle cell lymphoma?
When AML becomes resistant to to the first chemotherapy, what are the next steps?
For metastatic esophageal cancer, if the first line of chemotherapy treatment stops working, what are the next steps?
Note: All content on this site is informational and not a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider with questions regarding your health.
Note: Usernames have been made anonymous and profile images are not shown to protect the privacy of our members.
Flag Content
Please explain why you are flagging this content. Thank you.
Thank you for flagging this content. We will look into it right away.
Give a 'Thank you' to
Close
Talk About Health
Add Answer

Close
1) Question:
2) Background Info (optional): What context or background information is relevant to this request?
Notes:
The more clear and thorough your request, the more likely you will receive support.
Many of our members are learning from this information or english might not be their first language. Please use standard english and spell out all words. For example, use 'you' instead of 'u'.
Newsletters
Close
Subscribe to our free updates for the latest news, best answers and featured experts!
Your Email:
Q&A Workshop Announcements
(Featured experts, answers, tips, & latest news.)
Q&A Workshop Summaries
(Answer summaries from our expert Q&A workshops.)
Best of TalkAboutHealth (weekly)
(The week's best answers, news & support.)
TalkAboutHealth Benefits
(Custom health, wellness & medical promotions from our partners including clinical trials, market research opportunities, & new programs.)

Partners become a partner

© Copyright 2013 - Talk About Health - Privacy Policy | Terms of Service